Intended for healthcare professionals

News

Coca-Cola and obesity: study shows efforts to influence US Centers for Disease Control

BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l471 (Published 30 January 2019) Cite this as: BMJ 2019;364:l471
  1. Gareth Iacobucci
  1. The BMJ

Correspondence between the Coca-Cola Company and the US Centers for Disease Control and Prevention (CDC) has revealed Coke’s efforts to influence the agency’s approach to tackling obesity, a new study has found.

Published in the Milbank Quarterly,1 the paper said that emails reveal Coke’s interest in “gaining access to CDC employees, to lobby policymakers, and to frame the obesity debate by shifting attention and blame away from sugar-sweetened beverages.”

The emails also demonstrate Coke’s efforts to “advance corporate objectives, rather than health, including to influence the World Health Organization,” says the study.

FOI requests

The paper follows an investigation published by The BMJ last month,2 which showed how Coke had shaped obesity science and steered public health policy towards its own interests in China.

The latest study was based on emails …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription